Back to Search
Start Over
Angiotensin II blocker decreases serum prostate specific antigen in hormone refractory prostate cancer.
- Source :
-
The Journal of urology [J Urol] 2005 Feb; Vol. 173 (2), pp. 441. - Publication Year :
- 2005
- Subjects :
- Aged
Angiotensin II Type 1 Receptor Blockers therapeutic use
Antineoplastic Agents, Hormonal therapeutic use
Benzimidazoles therapeutic use
Biphenyl Compounds
Humans
Male
Prostatic Neoplasms drug therapy
Tetrazoles therapeutic use
Treatment Failure
Angiotensin II Type 1 Receptor Blockers pharmacology
Benzimidazoles pharmacology
Prostate-Specific Antigen blood
Prostate-Specific Antigen drug effects
Prostatic Neoplasms blood
Tetrazoles pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 0022-5347
- Volume :
- 173
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- The Journal of urology
- Publication Type :
- Academic Journal
- Accession number :
- 15643197
- Full Text :
- https://doi.org/10.1097/01.ju.0000148855.17830.97